低聚肽强化麦芽糊精果糖液对胃癌患者临床效果的影响

doi:10.16689/j.cnki.cn11-9349/r.2020.04.011

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (516 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨低聚肽强化麦芽糊精果糖液对胃癌患者加速康复外科临床效果的影响。方法应用随机数字表法将2017年10月至2019年12月在南京医科大学附属淮安第一医院行胃癌根治术的110例胃癌患者随机分为对照组和联合组，各55例。对照组患者给予常规饮食指导和综合干预措施；联合组患者在对照组基础上术前及术后加服12.5%麦芽糊精果糖饮品及鸡蛋膜活性肽。观察两组患者术后康复效果。结果联合组患者术中补液总量较对照组明显减少，术后首次通气时间、术后排便时间、术后住院时间和住院总费用较对照组明显缩短和减少（P<0.05）。联合组术后7d的白蛋白、总蛋白、前白蛋白和血红蛋白水平相比对照组均明显升高（P<0.05）。术前两组患者的欧洲癌症研究与治疗组织（EORTC）生活质量核心问卷调查（QLQ-C30）评分比较差异无统计学意义（P>0.05），术后除认知功能领域外联合组的EORTC QLQ-C30其他各项目评分与对照组比较差异均有统计学意义（P<0.05）。结论常规加速康复外科杂志联合低聚肽强化干预能增加行胃癌根治术患者空腹状态下的能量及氮储备，改善其围术期主观感受和短期营养状况，有利于患者术后的快速康复和生活质量的提高。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘刚
	沈旸

关键词 ：胃癌, 低聚肽, 加速康复外科, 临床效果

Abstract：ObjectiveTo investigate the effect of oligopeptide strengthening maltodextrin fructose solution on the clinical effect of accelerated rehabilitation surgery in gastric cancer patients. MethodsUsing the random number table method, 110 patients with gastric cancer who underwent radical gastric cancer surgery at the Affiliated Huaian NO.1 Peoples Hospital of Nanjing Medical University from October 2017 to December 2019 were randomly divided into a control group and a combined group, with 55 cases in each group. The patients in the control group were given routine diet instruction and comprehensive intervention, the patients in the combined group were given 12.5% maltodextrin fructose drinks and egg membrane active peptide during the perioperative period based on the control group. The postoperative rehabilitation effect between the two groups were compared. ResultsCompared with the control group, the total amount of intraoperative fluid infusion in the combined group was significantly reduced, and the first ventilation time, defecation time, intravenous infusion time, hospitalization time and total hospitalization cost were significantly reduced (P<0.05). The levels of albumin, total protein, prealbumin and hemoglobin in the combined group were significantly higher than those in the control group (P<0.05). The incidence of postoperative infection in the combined group was lower than that in the control group, but the difference was not statistically significant (P>0.05). There were significant differences in the quality of life core 30 questionnaire (QLQ-C30) score of European Organization for research and treatment of cancer (EORTC) scores between the combined group and the control group after operation, except in the field of cognitive function (P<0.05). Conclusion ERAS combined with oligopeptide-enhanced intervention can increase the energy and nitrogen reserve of patients under the condition of fasting, it can further promote their subjective feelings during the perioperative period and nutritional status in the near future, which is conducive to the overall rapid recovery and improvement of quality of life.

Key words： Gastric cancer Oligopeptide Enhanced recovery after surgery Clinical efficacy

基金资助:江苏省医院协会医院管理创新研究课题（JSYGY-2-2017-194）

通讯作者: 沈旸，电子邮箱：sy16051@163.com

引用本文:

刘刚，沈旸. 低聚肽强化麦芽糊精果糖液对胃癌患者临床效果的影响[J]. 肿瘤代谢与营养电子杂志, 2020, 7(4): 433-437.
Liu Gang, Shen Yang. The effect of oligopeptide-enhanced maltodextrin fructose solution on accelerated rehabilitation surgery in gastric cancer patients. Electron J Metab Nutr Cancer, 2020, 7(4): 433-437.

1.刘通,魏垚臣,梁明杨,等.不同体质量指数与消化系统肿瘤发病关系的多中心回顾性研究(附95177例报告)［J］. 中华消化外科杂志,2019,18(1):74-82.
2.金育德,朱炜,戴闯,等.术前口服糖溶液对胃癌手术患者胰岛素抵抗和氧化应激的影响［J］. 中华内分泌外科杂志,2017,11(3):210-214.
3.韩蔷,冯金华,许瑞华.缩短禁食时间在腹腔镜胆囊切除病人围手术期管理中的应用效果评价［J］.安徽医药,2019,23(4):768-771.
4.LARY A R, TAWEE T, DEANNA G, et al. Preoperative nutrition-enhanced recovery after surgery protocol for thoracic neoplasms［J］. J Thorac Cardiovasc Surg,2020,20(6):5223.
5.PAN F,TU X A,ZHANG X P,et al. Application of ERAS concept in andrological surgery［J］. C M J,2019,99(24):1844-1847.
6.MCQUEEN K, OODIT R, DERBEW M, et al. Enhanced recovery after surgery for low- and middle-income countries［J］. World J Surg,2018,42(4):950-952.
7.MUSORO Z J, HAMEL J F, EDIEBAH D E, et al. Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol［J］. Bmj Open,2018,8(1):e019117.
8.QIANG H U,HANG L U,SHUI SUN Y. The curative effect of early use of enteral immunonutrition in postoperative gastric cancer: a meta-analysis［J］. Minerva Dietol G,2017,63(3):285-292.
9.DALIRI E B M, DEOG H O, BYONG H L. Bioactive Peptides［J］. Foods,2017,6(5):32.
10.WON H R, AN J Y ,LEE JUNG J U N, et al. The effectiveness of an enhanced recovery after surgery protocol in head and neck cancer surgery with free-flap reconstruction［J］. Ann Surg Treatres,2019,97(5):239-244.
11.中国研究型医院学会机器人与腹腔镜外科专业委员会.胃癌胃切除手术加速康复外科专家共识(2016版)［J］. 中华消化外科杂志,2017,16(1):14-18.
12.RUBINKIEWICZ MATEUSZ, WITOWSKI J, SU MICHAEL,et al. Enhanced recovery after surgery (ERAS) programs for esophagectomy.［J］. J Thorac Dis,2019,11(5):685-691.
13.DAVID D KIM, PARKE E W, DOMINIQUE S MICHAUD, et al. Cost effectiveness of nutrition policies on processed meat: implications for cancer burden in the U.S.［J］. Am J Prev Med,2019,57(5):143-152.
14.KLEK S, SCISLO L, WALEWSKA E, et al. Enriched enteral nutrition may improve short-term survival in stage IV gastric cancer patients: a randomized, controlled trial.［J］. Nutrition ,2017,36(5):46-53.
15.郭会敏,徐曼曼,孔明,等.个体化营养干预对有营养风险的慢加急性肝衰竭患者预后的影响［J］.北京医学,2019,41(10):957-959,962.
16.RAMESH C, SAGAR K V, VEERENDRA KUMAR, et al. Perioperative artificial enteral nutrition in malnourished esophageal and stomach cancer patients and its impact on postoperative complications［J］. J Surg Oncol,2019,10(3):460-464.
17.DING J, SUN BL, SONG P, et al. The application of Enhanced Recovery After Surgery/Fast Track Surgery in gastrectomy for gastric cancer: a systematic review and meta-analysis［J］. Oncotarget, 2017,8(43):75699-75711
18.NORIHIKO S, MASANORI TOK, RIE M, et al. A phase II study of an enhanced recovery after surgery protocol in gastric cancer surgery［J］. Gastric Cancer,2016,19(3): 961-967.
19.AELEE JANG, OH JEONG. Early postoperative oral feeding after total gastrectomy in gastric carcinoma patients: a retrospective before-after study using propensity score matching［J］. JPEN J Parenter Enteral Nutr,2019,43(5):649-657.
20.PANG KARL H, GROVES R, VENUGOPAL S, et al. Prospective implementation of enhanced recovery after surgery protocols to radical cystectomy［J］. European urology,2018,73(3):363-371.
21.LI N M, LIU F, LV F Y , et al. Influencing factors and interventional strategies for early enteral nutrition after gastric carcinoma surgery［J］. J Cancer Res Ther,2016,12(2): 689-692.
22.WANG W K, TU C Y , SHAO C X , et al. Impact of enhanced recovery after surgery on postoperative rehabilitation, inflammation, and immunity in gastric carcinoma patients: a randomized clinical trial.［J］. Braz J Med Biol Res,2019,52(5):8265-8271.
23.KATHERINE B H, SHREYAS B, SHAAN M R, et al. Enhanced recovery after surgery for oncological craniotomies［J］. J Clin Neurosci,2016,24(3):10-16.
24.JI W P, ARVINE C D, GUO X L, et al. Enhanced recovery after surgery decreases intestinal recovery time and pain intensity in patients undergoing curative gastrectomy［J］. Cancer Manag Res,2018,18(3):3513-3520.
25.SPANIER B, ROHM F. Proton coupled oligopeptide transporter 1 (PepT1) function, regulation, and influence on the intestinal homeostasis［J］. Compr Physiol,2018,8(2):843-869.